The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart
缺血后心脏非梗塞但损伤心肌的识别和病理生理学
基本信息
- 批准号:10156372
- 负责人:
- 金额:$ 76.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteApoptosisArrhythmiaBiological ModelsCardiacCardiac Electrophysiologic TechniquesCardiac MyocytesCardiologyCell DeathCharacteristicsChronicChronic PhaseDataDenervationDiagnosisEFRACElectrophysiology (science)EventEvolutionExhibitsFunctional disorderGoalsHeartHeterogeneityHypertrophyImageImaging TechniquesImpairmentInfarctionInjuryInvestigationIschemiaKnowledgeLifeLinkMapsMeasurementMethodologyMethodsMolecularMyocardialMyocardial IschemiaMyocardial dysfunctionMyocardiumNecrosisNeuronsOxidative StressPathologicPathologyPathway interactionsPhasePhosphatidylethanolaminePrognosisProteomicsReperfusion TherapyResearchResearch PersonnelResidual stateRiskRoleShapesSignal PathwaySignal TransductionSpecificityTestingTissuesVentricular Arrhythmiaacute coronary syndromebasecell typeclinical Diagnosisclinical practiceclinically relevantfunctional disabilityimage guidedin vivoin vivo imaginginjuredinsightknowledge basemyocardial injurynerve supplynovelpersonalized careprognostic valueresponsespatiotemporaltissue injurytooltranscriptomics
项目摘要
ABSTRACT - In the post-ischemic heart, relatively little is known about the injured-but-not-infarcted myocardium,
which we call the intermediate zone as it is neither normal nor infarcted. We recently identified compelling
evidence that the intermediate zone is not merely a "lesser infarct", but has a set of unique pathological
characteristics and contributes significantly to cardiac impairment. These novel discoveries were made possible
by overcoming a technological challenge. We developed a high-sensitivity phosphatidylethanolamine (PE)-
based imaging technique, enabling the mapping of the intermediate zone which is otherwise missed by
conventional methods. Using imaging-guided pathological analyses, we discovered that, in contrast to the infarct
zone where there is necrosis across all cell types, in the intermediate zone different cell types survive differently.
This disparity between surviving cardiomyocytes (residual contractility) and loss of sympathetic neurons
(dysinnervation) creates chaos in electrophysiology. Chronically, the intermediate zone exhibits functional
deficiency with signaling activation associated with hypertrophy. The data strongly support that the intermediate
zone has significant contractile dysfunction as well as being a substrate for arrhythmias. As such, there are
significant prognostic values both for assessing the full scope of myocardial impairment and for predicting the
risk for arrhythmias. Based on these findings, we propose a central hypothesis that the intermediate zone
constitutes a distinct pathological entity which contributes to cardiac dysfunction in the post-ischemic heart. The
hypothesis will be tested in three integrated and synergistic Specific Aims: 1) to refine the in vivo imaging
methodology for mapping the intermediate zone, and characterize the pathology of this tissue in an imaging-
guided approach; 2) to determine the signaling changes in the intermediate zone; and 3) to investigate the roles
of the intermediate zone in arrhythmogenesis. Collectively, the ability to positively identify the intermediate zone
in vivo provides a critical technological breakthrough. By understanding the signaling, pathological and functional
changes in this tissue, our findings will ultimately have a transformative impact on enriching the knowledge base
and shaping clinical practices in ACS.
摘要-在缺血后心脏中,对损伤但未梗死的心肌了解相对较少,
我们称之为中间区,因为它既不正常也不梗塞。我们最近发现
有证据表明,中间区不仅仅是一个“较小的梗死”,但有一套独特的病理
特征,并显著导致心脏损害。这些新奇的发现
通过克服技术挑战。我们开发了一种高灵敏度的磷脂酰乙醇胺(PE)-
基于成像技术,能够映射中间区域,否则会被错过
常规方法。通过影像学引导的病理分析,我们发现,与梗死相比,
在所有细胞类型都有坏死的区域中,在中间区域中,不同的细胞类型以不同的方式存活。
存活的心肌细胞(残余收缩力)和交感神经元丢失之间的差异
(神经支配障碍)在电生理学中造成混乱。长期以来,中间区表现出功能性
缺乏与肥大相关的信号传导激活。数据有力地支持了中间体
区具有显著的收缩功能障碍以及作为心律失常的基质。因此,
对于评估心肌损伤的全部范围和预测
心律失常的风险。基于这些发现,我们提出了一个中心假设,即中间区
构成了导致缺血后心脏的心功能障碍的独特病理实体。的
将在三个综合和协同的具体目标中检验假设:1)改进体内成像
用于映射中间区的方法,并在成像中表征该组织的病理学,
引导方法; 2)确定中间区的信号变化; 3)调查
是一个过渡带。总的来说,积极识别中间区的能力
提供了关键的技术突破。通过了解信号,病理和功能
我们的发现最终将对丰富知识基础产生变革性的影响,
和塑造ACS的临床实践。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rishi Arora其他文献
Rishi Arora的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rishi Arora', 18)}}的其他基金
New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation
针对心房颤动的基本分子机制的新的颠覆性治疗方法
- 批准号:
10355010 - 财政年份:2022
- 资助金额:
$ 76.62万 - 项目类别:
New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation
针对心房颤动的基本分子机制的新的颠覆性治疗方法
- 批准号:
10553282 - 财政年份:2022
- 资助金额:
$ 76.62万 - 项目类别:
The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart
缺血后心脏非梗塞但损伤心肌的识别和病理生理学
- 批准号:
10551803 - 财政年份:2021
- 资助金额:
$ 76.62万 - 项目类别:
The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart
缺血后心脏非梗塞但损伤心肌的识别和病理生理学
- 批准号:
10322433 - 财政年份:2021
- 资助金额:
$ 76.62万 - 项目类别:
Disruption of Autonomic Pathways in the Left Atrium by Inhibition of G-proteins
抑制 G 蛋白扰乱左心房的自主神经通路
- 批准号:
8402335 - 财政年份:2009
- 资助金额:
$ 76.62万 - 项目类别:
Disruption of Autonomic Pathways in the Left Atrium by Inhibition of G-proteins
抑制 G 蛋白扰乱左心房的自主神经通路
- 批准号:
8243527 - 财政年份:2009
- 资助金额:
$ 76.62万 - 项目类别:
Disruption of Autonomic Pathways in the Left Atrium by Inhibition of G-proteins
抑制 G 蛋白扰乱左心房的自主神经通路
- 批准号:
7795813 - 财政年份:2009
- 资助金额:
$ 76.62万 - 项目类别:
Disruption of Autonomic Pathways in the Left Atrium by Inhibition of G-proteins
抑制 G 蛋白扰乱左心房的自主神经通路
- 批准号:
7656544 - 财政年份:2009
- 资助金额:
$ 76.62万 - 项目类别:
Disruption of Autonomic Pathways in the Left Atrium by Inhibition of G-proteins
抑制 G 蛋白扰乱左心房的自主神经通路
- 批准号:
8444322 - 财政年份:2009
- 资助金额:
$ 76.62万 - 项目类别:
Disruption of Autonomic Pathways in the Left Atrium by Inhibition of G-proteins
抑制 G 蛋白扰乱左心房的自主神经通路
- 批准号:
7837336 - 财政年份:2009
- 资助金额:
$ 76.62万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 76.62万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 76.62万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 76.62万 - 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 76.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 76.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 76.62万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 76.62万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 76.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 76.62万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 76.62万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




